Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Spinal Stabilization Exercise Effects in Hypermobility

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02869373
Recruitment Status : Completed
First Posted : August 16, 2016
Last Update Posted : August 16, 2016
Sponsor:
Information provided by (Responsible Party):
Seyda TOPRAK CELENAY, Ataturk Training and Research Hospital

Brief Summary:
The aim of this study is to investigate the effects of an 8-week lumbar spinal stabilization exercise program on pain, trunk muscle endurance and postural stability in women with benign joint hypermobility syndrome

Condition or disease Intervention/treatment Phase
Hypermobility Syndrome Behavioral: spinal stabilizaton exercise Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 38 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Assistant Professor
Study Start Date : April 2015
Actual Primary Completion Date : July 2015
Actual Study Completion Date : October 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise
spinal stabilization exercise program was applied
Behavioral: spinal stabilizaton exercise
In Exercise group, spinal stabilization exercise program was carried out 3 days a week for 8 weeks.

No Intervention: Control



Primary Outcome Measures :
  1. Change in musculoskeletal pain intensity as measured by Visual Analog Scale [ Time Frame: Change from baseline musculoskeletal pain intensity at 8 weeks ]

Secondary Outcome Measures :
  1. Change in trunk muscle endurance as measued with McGill's trunk muscle endurance tests [ Time Frame: Change from baseline trunk muscle endurance at 8 weeks ]
  2. Change in postural stability as measured with Biodex Balance System SD [ Time Frame: Change from baseline postural stability at 8 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • volunteers in an age range of 18 to 30,
  • being women,
  • having benign joint hypermobility syndrome diagnosed according to the Brighton criteria,
  • having no contraindication to join an exercise program.

Exclusion Criteria:

  • having rheumatologic or neurologic diseases,
  • any other pathology involving the musculoskeletal system-history of fractures, joint dislocations, sprains and strains,
  • associated connective tissue disorders including Marfan syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta,
  • severe psychological disorders,
  • being pregnant,
  • intervention including exercise or physical therapy in the last 3 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02869373


Sponsors and Collaborators
Ataturk Training and Research Hospital
Investigators
Layout table for investigator information
Study Director: Seyda TOPRAK CELENAY Yildirim Beyazit University
Principal Investigator: Derya OZER KAYA Izmir Katip Celebi University
Layout table for additonal information
Responsible Party: Seyda TOPRAK CELENAY, Assistant Professor, Ataturk Training and Research Hospital
ClinicalTrials.gov Identifier: NCT02869373    
Other Study ID Numbers: 2015-64/82
First Posted: August 16, 2016    Key Record Dates
Last Update Posted: August 16, 2016
Last Verified: August 2016